Namenda XR (memantine HCl), 7 mg extended release capsules, 30-count bottle, Rx only, Forest Pharmaceuticals Inc., St. Louis, MO 63045, NDC 0456-3407-33
Published February 12, 2014 · Recall initiated: November 13, 2013
Summary
FDA records drug Class III recall D-1063-2014, published February 12, 2014 and initiated November 13, 2013. Recalling firm: Forest Pharmaceuticals Inc; Status: Terminated; Reported quantity: 156 bottles; Lot: Lot 1111291 Exp. 02/16. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Dissolution Specifications: Three lots of product being recalled having failed stability dissolution testing.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Forest Pharmaceuticals Inc
- Distributor
- Nationwide and Puerto Rico.
- Lot
- Lot 1111291 Exp. 02/16
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDABystolic (nebivolol) tablets, 20 mg/tablet, packaged as 7 tablets/bottle/carton, and 12 bottles/trays,October 29, 2014
- FDABystolic (nebivolol) tablets, 20 mg/tablet. 7 Tablet Professional Sample Bottle, Rx Only. ForestJuly 9, 2014
- FDABystolic (nebivolol), 20 mg/tablet, 30 tablets per bottle, Rx only, Licensed from Mylan Laboratories Inc.,May 28, 2014
- FDANamenda XR (memantine HCl), sample pack, 28 mg, extended release capsules, packaged in 5-count sample packs,February 12, 2014
- FDACHILDREN'S IBUPROFEN, ORAL SUSPENSION, 200 mg/10mL cup BERRY FLAVOR, ALCOHOL FREE, MFG: ACTAVIS, PGK BYFebruary 12, 2014
- FDANamenda XR (memantine HCl), titration pack (7 mg, 14 mg, 21 mg and 28 mg) extended release capsules, packagedFebruary 12, 2014
Questions about this recall
Was Namenda XR (memantine HCl), 7 mg extended release capsules, 30-count bottle, Rx only, Forest Pharmaceuticals Inc., St. Louis, MO 63045, NDC 0456-3407-33 recalled?
Yes. FDA published recall D-1063-2014 on February 12, 2014. Reported hazard: Failed Dissolution Specifications: Three lots of product being recalled having failed stability dissolution testing.
What should I do if I have this product?
Voluntary: Firm initiated · Letter